Ethyl Pyruvate Has Anti-inflammatory and delayed myocardial protective effects after regional Ischemia/Reperfusion injury

Yonsei Medical Journal

Volumn 51, Issue 6, 2010, Pages 838-844

  Jang, In Seok ^a   Park, Mi Young ^a   Shin, Il Woo ^a   Sohn, Ju Tae ^a   Lee, Heon Keun ^a   Chung, Young Kyun ^a  

^a Gyeongsang National University   (South Korea)

Author keywords

Ethyl pyruvate; Inflammation; Myocardium; Reperfusion injury

Indexed keywords

CYTOKINE; ETHYLPYRUVIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYELOPEROXIDASE; PYRUVIC ACID DERIVATIVE; RINGER LACTATE SOLUTION; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; HEART FUNCTION; HEART INFARCTION SIZE; HEART PROTECTION; HEMODYNAMICS; INFLAMMATION; LEUKOCYTE ACTIVATION; MALE; NONHUMAN; RAT; REPERFUSION INJURY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL NUCLEUS; CYTOPLASM; HEART; INFLAMMATION; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; NF-KAPPA B; PEROXIDASE; PYRUVATES; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY;

EID: 77957941162     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2010.51.6.838     Document Type: Article

References (27)

1. Mallet RT, Sun J, Knott EM, Sharma AB, Olivencia-Yurvati AH. Metabolic cardioprotection by pyruvate: recent progress. Exp Biol Med 2005;230:435-43.
2. Brand KA, Hermfisse U. Aerobic glycolysis by proliferating cells: a protective strategy against reactive oxygen species. FASEB J 1997;11:388-95.
3. Dobsak P, Courderot-Masuyer C, Zeller M, Vergely C, Laubriet A, Assem M, et al. Antioxidative properties of pyruvate and protection of the ischemic rat heart during cardioplegia. J Cardiovasc Pharmacol 1999;34:651-9.
4. Yu YM, Kim JB, Lee KW, Kim SY, Han PL, Lee JK. Inhibition of the cerebral inchemic injury by ethyl pyruvate with a wide therapeutic window. Stroke 2005;36:2238-43.
5. Cicalese L, Lee K, Schraut W, Watkins S, Borle A, Stanko R. Pyruvate prevents ischemia-reperfusion mucosal injury of rat small intestine. Am J Surg 1996;171:97-100.
6. Sileri P, Schena S, Morini S, Rastellini C, Pham S, Benedetti E, et al. Pyruvate inhibits hepatic ischemia-reperfusion injury in rats. Transplantation 2001;72:27-30.
7. Fink MP. Ethyl pyruvate. Curr Opin Anaesthesiol 2008;21:160-7.
8. Taylor MD, Grand TJ, Cohen JE, Hsu V, Liao GP, Zentko S, et al. Ethyl pyruvate enhances ATP levels, reduces oxidative stress and preserves cardiac function in a rat model of off-pump coronary bypass. Heart Lung Circ 2005;14:25-31.
9. Woo YJ, Taylor MD, Cohen JE, Jayasankar V, Bish LT, Burdick J, et al. Ethyl pyruvate preserves cardiac function and attenuates oxidative injury after prolonged myocardial ischemia. J Thorac Cardiovasc Surg 2004;127:1262-9.
10. Kim HS, Cho IH, Kim JE, Shin YJ, Jeon JH, Kim Y, et al. Ethyl pyruvate has an anti-inflammatory effect by inhibiting ROSdependent STAT signaling in activated microglia. Free Radic Biol Med 2008;45:950-63.
11. Kim JB, Yu YM, Kim SW, Lee JK. Anti-inflammatory mechanism is involved in ethyl pyruvate-mediated efficacious neuroprotection in the postischemic brain. Brain Res 2005;1060:188-92.
12. Yang R, Han X, Delude RL, Fink MP. Ethyl pyruvate ameliorates acute alcohol-induced liver injury and inflammation in mice. J Lab Clin Med 2003;142:322-31.
13. Shin IW, Jang IS, Lee SH, Baik JS, Park KE, Sohn JT, et al. Propofol has delayed myocardial protective effects after a regional ischemia/reperfusion injury in an in vivo rat heart model. Korean J Anesthesiol 2010;58:378-82.
14. Jin YC, Kim CW, Kim YM, Nizamutdinova IT, Ha YM, Kim HJ, et al. Cryptotanshinone, a lipophilic compound of Salvia miltiorrhiza root, inhibits TNF-alpha-induced expression of adhesion molecules in HUVEC and attenuates rat myocardial ischemia/ reperfusion injury in vivo. Eur J Pharmacol 2009;614:91-7.
15. Gwechenberger M, Mendoza LH, Youker KA, Frangogiannis NG, Smith CW, Michael LH, et al. Cardiac myocytes produce interleukin-6 in culture and in viable border zone of reperfused infarctions. Circulation 1999;99:546-51.
16. Ulloa L, Ochani M, Yang H, Tanovic M, Halperin D, Yang R, et al. Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proc Natl Acad Sci U S A 2002;99:12351-6.
17. Zingarelli B, Hake PW, Yang Z, O'Connor M, Denenberg A, Wong HR. Absence of inducible nitric oxide synthase modulates early reperfusion-induced NF-kappaB and AP-1 activation and enhances myocardial damage. FASEB J 2002;16:327-42.
18. Chandrasekar B, Freeman GL. Induction of nuclear factor kappaB and activation protein 1 in postischemic myocardium. FEBS Lett 1997;401:30-4.
19. Barnes PJ, Karin M. Nuclear factor-kappaB; a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997; 336:1066-71.
20. Han Y, Englert JA, Yang R, Delude RL, Fink MP. Ethyl pyruvate inhibits nuclear factor-kappaB-dependent signaling by directly targeting p65. J Pharmacol Exp Ther 2005;312:1097-105.
21. Tsung A, Kaizu T, Nakao A, Shao L, Bucher B, Fink MP, et al. Ethyl pyruvate ameliorates liver ischemia-reperfusion injury by decreasing hepatic necrosis and apoptosis. Transplantation 2005; 79:196-204.
22. Reade MC, Fink MP. Bench-to-bedside review: Amelioration of acute renal impairment using ethyl pyruvate. Crit Care 2005;9: 556-60.
23. Hansen PR. Role of neutrophils in myocardial ischemia and reperfusion. Circulation 1995;91:1872-85.
24. Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res 2002;53:31-47.
25. Goldmann BU, Rudolph V, Rudolph TK, Holle AK, Hillebrandt M, Meinertz T, et al. Neutrophil activation precedes myocardial injury in patients with acute myocardial infarction. Free Radic Biol Med 2009;47:79-83.
26. Zhao ZQ, Nakamura M, Wang NP, Velez DA, Hewan-Lowe KO, Guyton RA, et al. Dynamic progression of contractile and endothelial dysfunction and infarct extension in the late phase of reperfusion. J Surg Res 2000;94:133-44.
27. Zhao ZQ, Velez DA, Wang NP, Hewan-Lowe KO, Nakamura M, Guyton RA, et al. Progressively developed myocardial apoptotic cell death during late phase of reperfusion. Apoptosis 2001; 6:279-90.